Fentanyl
Fentanyl system
Opioid Agonist
NADAC/unit
$1.2354
Active Shortage
Tier 1: 117.9%
PA Req: 335.0%
5 Manufacturers
30 ANDAs
Fentanyl relieves moderate to severe pain by acting on opioid receptors in the brain.
vs. brand Fentanyl system: Generic saves up to 88% per unit
Active Shortages
2023-12-20 Inventory available in vial presentations., Hikma Pharmaceuticals USA, Inc.
2023-12-20 Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released., Hikma Pharmaceuticals USA, Inc.
2023-12-20 Inventory available in vial presentations., Hikma Pharmaceuticals USA, Inc.
2023-12-20 Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released., Hikma Pharmaceuticals USA, Inc.
2023-12-20 Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released., Hikma Pharmaceuticals USA, Inc.
Market Intelligence
2025-02-26 Class I Recall: Alvogen, Inc
Generic Manufacturers
DIFGEN PHARMACEUTICALS LLCFRESENIUS KABI USA LLCHIKMA PHARMACEUTICALS USA INCHOSPIRA INCKINDEVA DRUG DELIVERY LPMYLAN TECHNOLOGIES INCRISING PHARMA HOLDINGS INCSPECGX LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.